trending Market Intelligence /marketintelligence/en/news-insights/trending/qbtk1jgpk4ioboyo1uqhyq2 content esgSubNav
In This List

UK court backs Boston Scientific claims in patent case vs Edwards Lifesciences

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


UK court backs Boston Scientific claims in patent case vs Edwards Lifesciences

The U.K. Court of Appeal ruled in favor of Boston Scientific Corp. in a patent infringement case against Edwards Lifesciences Corp.

The British court dismissed an appeal by Edwards Lifesciences and upheld a March 2017 court ruling that Edwards Lifesciences' Sapien 3 transcatheter heart valve infringed on a Boston Scientific patent and that all claims of that patent are valid.

The U.S. Patent and Trademark Office previously favored in favor of Edwards Lifesciences earlier in March 2018 in an inter partes review of Boston Scientific's claims regarding its transcatheter heart valve.

Boston Scientific plans to appeal the patent agency's finding.

Marlborough, Mass.-based Boston Scientific had filed a patent case against Irvine, Calif.-based Edwards Lifesciences in Delaware in 2016.